SCHEMBL1415402

SCHEMBL1415402

O=C(O)c1cnn(-c2nc3cc(F)cc(Br)c3[nH]2)c1

nearest known ligand 0.68

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
EGLN1 Q9GZT9 20/20 0.68

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12875903 0.87 EGLN1 (0.61) EGLN1
SCHEMBL1415304 0.86 EGLN1 (0.68) EGLN1
SCHEMBL1415774 0.84 EGLN1 (0.49) EGLN1
SCHEMBL1193229 0.83 EGLN1 (0.68) EGLN1
SCHEMBL1193218 0.83 EGLN1 (0.68) EGLN1
SCHEMBL1193373 0.82 EGLN1 (0.71) EGLN1
SCHEMBL1192898 0.81 EGLN1 (1.00) EGLN1
SCHEMBL1192380 0.79 EGLN1 (0.68) EGLN1
SCHEMBL1193403 0.79 EGLN1 (0.91) EGLN1
SCHEMBL1192460 0.78 EGLN1 (0.82) EGLN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2294066-A1 BENZOIMIDAZOLES AS PROLYL HYDROXYLASE INHIBITORS Janssen Pharmaceutica, N.V. (BE) 2011-03-16 EP disclosed
WO-2009134750-A1 BENZOIMIDAZOLES AS PROLYL HYDROXYLASE INHIBITORS JANSSEN PHARMACEUTICA NV (BE) 2009-11-05 WO disclosed